BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27742851)

  • 1. The role of calculated non-caeruloplasmin-bound copper in Wilson's disease.
    Duncan A; Yacoubian C; Beetham R; Catchpole A; Bullock D
    Ann Clin Biochem; 2017 Nov; 54(6):649-654. PubMed ID: 27742851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers for diagnosis of Wilson's disease.
    Ryan A; Nevitt SJ; Tuohy O; Cook P
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31743430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into the pathogenesis of copper toxicosis in Wilson's disease: evidence for copper incorporation and defective canalicular transport of caeruloplasmin.
    Chowrimootoo GF; Ahmed HA; Seymour CA
    Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):851-5. PubMed ID: 8645167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective biliary copper excretion in Wilson's disease: the role of caeruloplasmin.
    Davis W; Chowrimootoo GF; Seymour CA
    Eur J Clin Invest; 1996 Oct; 26(10):893-901. PubMed ID: 8911863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper distribution among serum proteins in paediatric liver disorders and malignancies.
    Barrow L; Tanner MS
    Eur J Clin Invest; 1988 Dec; 18(6):555-60. PubMed ID: 3147183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wilson's disease: the importance of measuring serum caeruloplasmin non-immunologically.
    Walshe JM;
    Ann Clin Biochem; 2003 Mar; 40(Pt 2):115-21. PubMed ID: 12662398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced oxidase activity in the caeruloplasmin of two families with Wilson's disease.
    Gollan JL; Stocks J; Dormandy TL; Sherlock S
    J Clin Pathol; 1977 Jan; 30(1):81-3. PubMed ID: 838874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper:caeruloplasmin ratio.
    Twomey PJ; Viljoen A; House IM; Reynolds TM; Wierzbicki AS
    J Clin Pathol; 2007 Apr; 60(4):441-2. PubMed ID: 17405985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is copper incorporation to caeruloplasmin normal in Wilson's disease?
    Chowrimootoo GF; Seymour CA
    Biochem Soc Trans; 1994 May; 22(2):191S. PubMed ID: 7958254
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on copper, caeruloplasmin and cirrhosis in relation to Wilson's disease.
    Williams AO
    Br J Exp Pathol; 1965 Oct; 46(5):564-8. PubMed ID: 5838405
    [No Abstract]   [Full Text] [Related]  

  • 11. A critical evaluation of copper metabolism in Indian Wilson's disease children with special reference to their phenotypes and relatives.
    Prasad R; Kaur G; Walia BN
    Biol Trace Elem Res; 1998 Nov; 65(2):153-65. PubMed ID: 9881519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct measurement of serum non-caeruloplasmin copper in liver disease.
    Frommer DJ
    Clin Chim Acta; 1976 May; 68(3):303-7. PubMed ID: 1277546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunocytochemical identification of caeruloplasmin in hepatocytes of patients with Wilson's disease.
    Graul RS; Epstein O; Sherlock S; Scheuer PJ
    Liver; 1982 Sep; 2(3):207-11. PubMed ID: 6184593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-ceruloplasmin-bound copper in routine clinical practice in different laboratories.
    Twomey PJ; Viljoen A; Reynolds TM; Wierzbicki AS
    J Trace Elem Med Biol; 2008; 22(1):50-3. PubMed ID: 18319140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-caeruloplasmin copper and ferroxidase activity in mammalian serum. Ferroxidase activity and phenanthroline-detectable copper in human serum in Wilson's disease.
    Evans PJ; Bomford A; Halliwell B
    Free Radic Res Commun; 1989; 7(1):55-62. PubMed ID: 2806955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caeruloplasmin oxidase activity: measurement in serum by use of o-dianisidine dihydrochloride on a microplate reader.
    Stepien KM; Guy M
    Ann Clin Biochem; 2018 Jan; 55(1):149-157. PubMed ID: 28166667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies with radioactive copper ( 64 Cu and 67 Cu); the incorporation of radioactive copper into caeruloplasmin in Wilson's disease and in primary biliary cirrhosis.
    Gibbs K; Walshe JM
    Clin Sci; 1971 Sep; 41(3):189-202. PubMed ID: 5571499
    [No Abstract]   [Full Text] [Related]  

  • 18. [Metabolism of ceruloplasmin and copper in the blood in Wilson's disease].
    Kanai M; Nomoto S; Tsukagoshi H; Shindo M
    Rinsho Byori; 1974 Oct; 22(10 Suppl):191. PubMed ID: 4475793
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma and erythrocyte copper, zinc, manganese and magnesium concentrations in Wilson's disease.
    Goto I; Kawano Y; Tsuchiya T; Tamagawa Y; Kuroiwa Y
    Clin Neurol Neurosurg; 1986; 88(3):193-6. PubMed ID: 3780108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjusting copper concentrations for caeruloplasmin levels in routine clinical practice.
    Twomey PJ; Viljoen A; House IM; Reynolds TM; Wierzbicki AS
    J Clin Pathol; 2006 Aug; 59(8):867-9. PubMed ID: 16644878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.